Đang chuẩn bị liên kết để tải về tài liệu:
Serum matrix metalloproteinase-13 as a diagnostic biomarker for cutaneous squamous cell carcinoma

Nam Lộc 25 8 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

A significant proportion of newly diagnosed patients with cutaneous squamous cell carcinoma (cSCC) have metastasis and eventually die of the disease, necessitating the exploration of novel biomarkers for early detection of cSCC aggressiveness, risk assessment and monitoring. |

TÀI LIỆU LIÊN QUAN

Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls

Two-dimensional gel-based serum protein profile of growing piglets

Cathepsin-S degraded decorin are elevated in fibrotic lung disorders – development and biological validation of a new serum biomarker

Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients

Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: A case–control study

Serum matrix metalloproteinase-13 as a diagnostic biomarker for cutaneous squamous cell carcinoma

Báo cáo y học: "Matrix-metalloproteinase-2, -8 and -9 in serum and skin blister fluid in patients with severe sepsis"

Báo cáo y học: "Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia"

Báo cáo y học: "Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept"

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.